Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) Revenue (2016 - 2026)

Orthofix Medical has reported Revenue over the past 17 years, most recently at $186.1 million for Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 2.47% year-over-year to $186.1 million, compared with a TTM value of $791.2 million through Mar 2026, up 6.81%, and an annual FY2025 reading of $822.3 million, up 9.97% over the prior year.
  • Revenue came in at $186.1 million for Q1 2026, down from $219.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $219.9 million in Q4 2025 to a low of $67.0 million in Q4 2022.
  • Median Revenue over the past 5 years was $175.8 million (2024), compared with a mean of $161.9 million.
  • The sharpest move saw Revenue plummeted 39.32% in 2022, then soared 119.73% in 2023.
  • Over 5 years, Revenue stood at $67.0 million in 2022, then soared by 119.73% to $147.1 million in 2023, then rose by 11.44% to $163.9 million in 2024, then soared by 34.13% to $219.9 million in 2025, then dropped by 15.37% to $186.1 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Revenue are $186.1 million (Q1 2026), $219.9 million (Q4 2025), and $193.8 million (Q3 2025).